Cite
HARVARD Citation
Baker, W. et al. (2019). Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes. Diabetes, obesity & metabolism. 21 (9), pp. 2107-2114. [Online].